Isopropyl glycidyl ether
|
CAS
4016-14-2
|
C6H12O2
|
RTECS
TZ3500000
|
Synonyms & Trade Names
1,2-Epoxy-3-isopropoxypropane; IGE; Isopropoxymethyl oxirane
|
DOT ID & Guide
|
Exposure
Limits
|
NIOSH REL: C 50 ppm (240 mg/m3) [15-minute]
|
|
OSHA PEL†: TWA 50 ppm (240 mg/m3)
|
IDLH
400 ppm
See: 4016142
|
Conversion
1 ppm = 4.75 mg/m3
|
Physical Description
Colorless liquid.
|
MW: 116.2
|
BP: 279°F
|
FRZ: ?
|
Sol: 19%
|
VP(77°F): 9 mmHg
|
IP: ?
|
|
Sp.Gr: 0.92
|
Fl.P: 92°F
|
UEL: ?
|
LEL: ?
|
|
|
Class IC Flammable Liquid: Fl.P. at or above 73°F and below 100°F.
|
Incompatibilities & Reactivities
Strong oxidizers, strong caustics [Note: May form explosive peroxides upon exposure to air or light.]
|
Measurement Methods
NIOSH 1620; OSHA 7
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet (flammable)
Change: No recommendation
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH/OSHA
Up to 400 ppm:
(APF = 25) Any supplied-air respirator operated in a continuous-flow mode£
(APF = 50) Any self-contained breathing apparatus with a full facepiece
Emergency or planned entry into unknown concentrations or IDLH conditions:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, skin, upper respiratory system; skin sensitization; possible hematopoietic, reproductive effects
|
Target Organs
Eyes, skin, respiratory system, blood, reproductive system
|
|
See also: INTRODUCTION
See ICSC CARD: 0171 See MEDICAL TESTS: 0125
|
